Clinical trial
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of…
NCT00492518 · Technical University of Munich, Other · Completed
Key facts
| NCT number | NCT00492518 |
|---|---|
| Title | Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy |
| Official title | Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy: A Placebo Controlled Randomized Study |
| Acronym | ATHENS |
| Lead sponsor | Technical University of Munich, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contrast Induced Nephropathy, Kidney Diseases, Renal Failure, Adverse Effects |
| Intervention type | Drug |
| Interventions | Acetylcysteine, Theophylline, Placebo |
| Enrollment | 254 |
| Start date | Feb 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Jun 27, 2007 |
| Last update posted | Jun 27, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: